1. Kevin Mullins National IAPT Director An Update on the LTC/MUS Project & National IAPT Programme March 2013

2. Improve access for older people and BME communities Complete roll-out of services for adults Initiate stand – alone programme for children and young people Talking Therapies: four – year plan of action Improve access to psychological therapies for people with Psychosis, Bipolar Disorder, Personality Disorder Talking Therapies 2011 - 2015 Develop models of care for: Long Term Conditions Medically Unexplained Symptoms

3. Start Point & Planning Assumptions 300k Recover (25k Move off Benefits) 600k complete treatment 900k present to services 6m in need

4. Map showing PCT with IAPT Services & Projects KEY No IAPT Service IAPT Service IAPT Service + PBR IAPT Service + LTC/MUS IAPT Service + CYP IAPT Service + SMI IAPT Service + PBR + CYP IAPT Service + PBR + SMI IAPT Service + CYP + SMI IAPT Service + CYP + LTC/MUS IAPT Service + PBR + LTC/MUS + CYP IAPT Service + LTC/MUS + CYP + SMI

5. LTC/MUS The Clinical Background Approximately 15 million people with LTCs; many LTC patients – mixture of multi-morbidity best addressed holistically There is a strong link between physical long term conditions and psychological distress/disorder LTCs (diabetes, CVD & COPD) 3-4 times prevalence; poorer health outcomes & inc costs MUS is often associated with significant psychological distress MUS can result in unnecessary and costly referrals, diagnostic tests & operative procedures Psychological treatment can improve outcomes and reduce health care consumption NICE recommends the use of psychological interventions in people with depression and chronic physical health problems.

6. IAPT LTC/MUS Project – Aim The IAPT LTC/MUS Project aims to extend the benefits of improved access to psychological therapies to people with long-term physical conditions and/or medically unexplained symptoms. The IAPT LTC/MUS Project aims to extend the benefits of improved access to psychological therapies to people with long-term physical conditions and/or medically unexplained symptoms.

7. Key questions to be addressed via the LTC/MUS pathfinders Is there an optimal stepped care pathway for LTC/MUS patients? What evidence supports each part of the pathfinder’s model of delivery? What core therapy competencies are required at each step of the pathway? Which health professional groups, in terms of both clinical and cost effectiveness, are best placed to offer care at each of these steps? What background experience and additional training is necessary at the different levels of stepped care? How potentially cost-effective and efficient are the different models? How can services intervene early with upstream interventions?